Michael O'Rourke
Job title
CEO
Company
Re-Vana Therapeutics
2025 Ophthalmology Futures Forums participation
Retina Forum, Paris 2025
11:20 - 11:50
Panel 3: Neovascular AMD: Are the Novel Extended Interval Therapies Truly Making a Difference?
13:50 - 15:20
Company Presentations 1